Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...

A machine learning-driven eNose detects ovarian cancer in blood plasma with 97 % sensitivity and specificity, offering a promising biomarker-agnostic approach.

Pancreatic cancer is one of the most dangerous forms of cancer in the world. Many patients do not know they have the disease ...

Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go ...

The cancer diagnostics industry is evolving rapidly as advances in biotechnology, data analytics and precision medicine ...

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free DNA (cfDNA) fragmentation patterns and repeat ...

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test ...

Imagine a screening method that’s more accurate in early detection than a mammogram and less expensive than an MRI. That’s ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...

The RSUs vest over an approximately four year period, with 25% of the award vesting Feb. 28, 2027, and on each one year anniversary of those respective dates thereafter, subject to continued ...

University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden ...